|
KBTBD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.02510230806752E-11 |
| Normal-vs-Stage3 |
1.50069999760305E-08 |
| Normal-vs-Stage4 |
1.95732319241415E-13 |
| Stage1-vs-Stage2 |
9.748400E-01 |
| Stage1-vs-Stage3 |
6.632800E-01 |
| Stage1-vs-Stage4 |
1.008180E-02 |
| Stage2-vs-Stage3 |
6.906800E-01 |
| Stage2-vs-Stage4 |
5.827800E-02 |
| Stage3-vs-Stage4 |
1.639590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.75470749042006E-12 |
| Normal-vs-Asian |
2.96230000529363E-08 |
| Caucasian-vs-AfricanAmerican |
3.913000E-01 |
| Caucasian-vs-Asian |
5.849600E-01 |
| AfricanAmerican-vs-Asian |
4.092200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.84099957500905E-10 |
| Male-vs-Female |
2.001800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.76100245496968E-11 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.70019553991096E-12 |
| Normal-vs-Extreme_Obese |
8.249400E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.240800E-01 |
| Normal_Weight-vs-Obese |
6.692600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.827200E-01 |
| Extreme_Weight-vs-Obese |
5.726400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.126200E-01 |
| Obese-vs-Extreme_Obese |
4.827000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.6132000000032E-06 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.47939993588864E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.064200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.442200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.432000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.652400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.647200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
7.88258347483861E-15 |
| Normal-VS-KIRP CIMP |
5.55839996252416E-09 |
| Normal-VS-Unclassified PRCC |
3.82910003704495E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.688180E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.477400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.134600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.610800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.583600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.284200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
4.05759981170206E-10 |
| Normal-vs-N2 |
6.36540000042984E-07 |
| N0-vs-N1 |
2.867400E-01 |
| N0-vs-N2 |
5.709400E-01 |
| N1-vs-N2 |
3.412200E-01 |
|
|
